Back to FRANKLIN TEMPLETON INC FRANKLIN TEMPLETON INC

CNTXCNTX
8 quarters

Position history for FRANKLIN TEMPLETON INCFRANKLIN TEMPLETON INC's holdings in CONTEXT THERAPEUTICS INC

Yes. Franklin Templeton holds 3,803,338 shares of CNTX (Context Therapeutics), worth $2.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Franklin Templeton has held CNTX since Q3 2024, across 8 quarterly 13F filings.

Current Value

$2.1M

Current Shares

3.8M

Total Value Change

-$1.6M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3.8M
0.0%
$2.1M0.0%$0.55
0
2026-Q1
Decreased
3.8M
-5.0%
$10M0.0%$2.38
0
2025-Q4
Unchanged
4M
0.0%
$5.9M0.0%$1.30
0
2025-Q3
Unchanged
4M
0.0%
$3.9M0.0%$0.97
0
2025-Q2
Unchanged
4M
0.0%
$2.6M0.0%$0.66
0
2025-Q1
Unchanged
4M
0.0%
$2.5M0.0%$0.65
0
2024-Q4
Increased
4M
+115.9%
$4.2M0.0%$1.06
43
2024-Q3
New
1.9M
-
$3.7M0.0%$1.86
37

Other major holders of CNTX: VANGUARD CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, VANGUARD GROUP INC, Blackstone Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used